Summary
MUC1 is a transmembrane molecule characterized by a repeated sequence of 20 amino acid (TAP PAHGVTSAPDTRPAPGS). Abnormal overexpression of MUC1 in cancer cells is thought to contribute to their aggressive growth, but molecular mechanisms associated with this effect are still unclear. Our current study aimed to clarify whether MUC1 expression as recognized by VU-3C6 anti-MUC1 mouse IgG monoclonal antibody (MAb) with a dominant epitope of 12 amino acids: GVTSAPDTRPAP, correlated with aggressive properties of human breast cancer. Immunohistochemical studies of 309 samples of formalin-fixed and paraffin-embedded materials showed no statistical correlation between MUC1 expression and clinicopathological parameters, as well as several breast cancer aggressiveness-related markers. Expression or nonexpression of MUC1 in 50 frozen samples, as determined by Western blotting, demonstrated no correlation with aggressive properties of breast cancer. However, samples with one MUC1-positive band more often had lymphatic vessel invasion and lymph node metastasis than those with more than two or three MUC1-positive bands (p<0.014 and p<0.043, respectively). Because VU-3C6 MAb recognizes MUC1 with short branches of O-glycosylated core carbohydrates, we used immunohistological methods to examine Tn antigen (precursor antigen: GalNAcα-O-Ser/Thr), Thomsen–Friedenreich (T) antigen, and sialyl-Tn antigen (STn) antigen. We found a strong correlation between expression of MUC1 and Tn antigen (p<0.0006), and samples with Tn antigen expression had more lymphatic metastasis than those with no such expression (p<0.08). We concluded that the lack of polymorphic MUC1 expression with Tn antigen is one characteristic related to aggressive breast cancer.
Similar content being viewed by others
References
The Editorial Board of the Cancer Statistics in Japan: Nomura K. editor-in-chief. Cancer statistics in Japan 2003 Tokyo, Foundation for Promotion of Cancer Research, National Cancer Center, 2003.
T Kawaguchi (2005) ArticleTitleCancer metastasis: characterization and identification of the behavior of metastatic tumor cells and the cell adhesion molecules, including carbohydrates Curr Drug Targets Cardiovasc Haematol Disord 5 39–64 Occurrence Handle10.2174/1568006053005038 Occurrence Handle15720223
LA Liotta EC Kohn (2001) ArticleTitleThe microenvironment of the tumour–host interface Nature Lond 411 375–379 Occurrence Handle10.1038/35077241 Occurrence Handle11357145
S Patton SJ Gendler AP Spicer (1995) ArticleTitleThe epithelial mucin, MUC1, of milk, mammary gland and other tissues Biochim et Biophys Acta 1241 407–424
MJ Ligtenberg F Buijs HL Vos J Hilkens (1992) ArticleTitleSuppression of cellular aggregation by high levels of episialin Cancer Res 52 2318–2324 Occurrence Handle1559234
J Wesseling SW Valk Particlevan der HL Vos A Sonnenberg J Hilkens (1995) ArticleTitleEpisialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components J Cell Biol 129 255–265 Occurrence Handle10.1083/jcb.129.1.255 Occurrence Handle7698991
P Pandey S Kharbanda D Kufe (1995) ArticleTitleAssociation of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein Cancer Res 55 4000–4003 Occurrence Handle7664271
JA Schroeder MC Adriance MC Thompson TD Camenisch SJ Gendler (2003) ArticleTitleMUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion Oncogene 22 1324–1332 Occurrence Handle10.1038/sj.onc.1206291 Occurrence Handle12618757
K Zhang R Sikut GC Hansson (1997) ArticleTitleA MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells Cell Immunol 176 158–165 Occurrence Handle10.1006/cimm.1997.1085 Occurrence Handle9073389
B Agrawal MJ Krantz MA Reddish BM Longenecker (1998) ArticleTitleCancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 Nature Med 4 43–49 Occurrence Handle10.1038/nm0198-043 Occurrence Handle9427605
F-G Hanisch S Müller (2000) ArticleTitleMUC1: the polymorphic appearance of a human mucin Glycobiology 10 439–449 Occurrence Handle10.1093/glycob/10.5.439 Occurrence Handle10764832
JM Burchell A Mungul J Taylor-Papadimitrou (2001) ArticleTitleO-linked glycosylation in the mammary gland: changes that occur during malignancy J Mammary Gland Biol Neoplasia 6 355–364 Occurrence Handle10.1023/A:1011331809881 Occurrence Handle11547903
MA McGuckin MD Walsh BG Hohn BG Ward RG Wright (1995) ArticleTitlePrognostic significance of MUC1 epithelial mucin expression in breast cancer Hum Pathol 26 432–439 Occurrence Handle10.1016/0046-8177(95)90146-9 Occurrence Handle7705823
JJ Rahn L Dabbagh M Pasdar JC Hugh (2001) ArticleTitleThe importance of MUC1 cellular localization in patients with breast carcinoma Cancer 91 1973–1982 Occurrence Handle10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A Occurrence Handle11391575
ML Alpaugh JS Tomlinson Y Ye SH Barsky (2002) ArticleTitleRelationship of sialyl-Lewisx/a underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma Am J Pathol 161 619–628 Occurrence Handle12163386
SE Baldus F-G Hanisch E Monaca UR Karsten TK Zirbes J Thile HP dienes (1999) ArticleTitleImmunoreactivity of Thomsen–Fridenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1 of carrier-specific glycotope expression on MUC1 Histol Histopathol 14 1153–1158 Occurrence Handle10506931
SJ Gendler EP Cohen A Craston T Duhig G Johnstone D Barnes (1990) ArticleTitleThe locus of the polymorphic epithelial mucin (PEM) tumour antigen on chromosome 1q21 shows a high frequency of alteration in primary human breast tumours Int J Cancer 45 431–435 Occurrence Handle2307533
AP Spicer GJ Rowse TK Lidner SJ Gendler (1995) ArticleTitleDelayed mammary tumor progression in Muc-1 null mice J Biol Chem 270 30009–30101
S Zrihan-Light M Weiss I Keydar DH Wreschner (1995) ArticleTitleDNA methylation status of the MUC1 gene coding for a breast-cancer-associated protein Int J Cancer 62 245–251 Occurrence Handle7628867
J Hilkens HL Vos J Wesseling J Boer S Storm J Storm Valk Particlevan der J Calafat C Patriarca (1995) ArticleTitleIs episialin/MUC1 involved in breast cancer progression Cancer Lett 90 27–33 Occurrence Handle10.1016/0304-3835(94)03674-8 Occurrence Handle7720039
MR Waltz SM Pandelidis W Pratt D Barnes DM Swalllow SJ Gendler EP Cohen (1998) ArticleTitleA microsatellite within the MUC1 locus at 1q21 is altered in the neoplastic cells of breast cancer patients Cancer Genet Cytogenet 100 63–67 Occurrence Handle10.1016/S0165-4608(97)00015-0 Occurrence Handle9406583
DJ Schol MFA Meulenbroek FJM Snijdewint S Mensdorff-Pouilly Particlevon RA Verstraeten F Murakami P Kenemans Jo Hilgers (1998) ArticleTitle‘Epitope fingerprinting’ using overlapping 20-mer peptides of the MUC1 tandem repeat sequence Tumor Biol 19 IssueIDsuppl 1 35–45 Occurrence Handle10.1159/000056503
InstitutionalAuthorName Breast Cancer Society (1989) ArticleTitleThe general rules for clinical and pathological recording of breast cancer Jpn J Surg 19 612–632
A Tsuchiya K Kanno T Kawaguchi Y Endo G-J Zhang T Ohtake I Kimijima (1999) ArticleTitlePrognostic relevance of Tn expression in breast cancer Breast Cancer 6 175–180 Occurrence Handle11091712
S Koyama S Terashima Y Takano T. Ohori J Inoue R Motoki T Kawaguchi (1997) ArticleTitlep53 protein expression of carcinoma cells associated with metastasis and prognosis in gastric carcinomas: a clinicopathological study Fukushima Igaku Zasshi 47 131–142
Y Matsushita N Yamamoto H Shirahama S Tanaka S Yonezawa T Yamori T Irimura E Sato (1995) ArticleTitleExpression of sulfomucins in normal mucosae, colorectal adenocarcinomas, and metastasis Jpn J Cancer Res 86 1060–1067 Occurrence Handle8567397
T Kawaguchi T Ono H Wakabayashi S Igarashi (1994) ArticleTitleCell surface laminin-like substances and laminin-related carbohydrates of rat ascites hepatoma AH7974 and its variants with different lung-colonizing potential Clin Exp Metastasis 12 203–212 Occurrence Handle10.1007/BF01753888 Occurrence Handle8194195
AN Houghton KO Lloyd (1998) ArticleTitleStuck in the MUC on the long and winding road Nature Med 4 270–271 Occurrence Handle10.1038/nm0398-270 Occurrence Handle9500594
SJ Gendler (2001) ArticleTitleMUC1, the renaissance molecule J Mammary Gland Biol Neoplasia 6 339–353 Occurrence Handle10.1023/A:1011379725811 Occurrence Handle11547902
I Ando A Kukita G Soma H Hino (1998) ArticleTitleLarge number of tandem repeats in the polymorphic epithelial mucin gene is associated with severe acne J Dermatol 25 150–152 Occurrence Handle9575675
K Denda-Nagai T Irimura (2000) ArticleTitleMUC1 in carcinoma–host interactions Glycoconj J 17 649–58 Occurrence Handle10.1023/A:1011039013134 Occurrence Handle11421355
S Müller K Alving J Peter-Katalinic N. Zachara AA Gooley F-G Hanisch (1999) ArticleTitleHigh density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells J Biol Chem 274 18165–18171 Occurrence Handle10.1074/jbc.274.26.18165 Occurrence Handle10373415
RA Walker (1990) ArticleTitleAssessment of milk fat globule membrane antibodies and lectins as markers of short-term prognosis in breast cancer Br J Cancer 62 462–646 Occurrence Handle2206956
J Burchell S Gendler J Taylor-Papadimitriou A Girling A Lewis R Millis D Lamport (1987) ArticleTitleDevelopment and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin Cancer Res 47 5476–5482 Occurrence Handle2443241
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawaguchi, T., Takazawa, H., Imai, S. et al. Lack of Polymorphism in MUC1 Tandem Repeats in Cancer Cells is Related to Breast Cancer Progression in Japanese Women. Breast Cancer Res Treat 92, 223–230 (2005). https://doi.org/10.1007/PL00021776
Issue Date:
DOI: https://doi.org/10.1007/PL00021776